Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CRO
Canadian $5M clinical trial program cuts start-up to 45 days
The QuickStart program initiated by Clinical Trials Ontario is an accelerated study start-up pathway to speed up patient access to clinical trials.
Marissa Russo
Sep 29, 2026 3:04pm
Why proving repeatability is the next hurdle for widespread adoption
Brought to you by
Agilent Technologies
Enanta sheds staffers as key readouts loom
Sep 29, 2026 1:30pm
Fierce Biotech Layoff Tracker 2026: Enanta, BMS & more
Sep 29, 2026 1:30pm
uniQure stock crashes as Huntington’s gene therapy data weaken
Sep 29, 2026 9:28am
ai3Bio buzzing with $48M for STING pathway targeting pipeline
Sep 29, 2026 9:00am
More News
Novo agrees $2.6B deal for Hengrui's preclinical GLP-1/GIP drug
Sep 29, 2026 3:50am
AstraZeneca scales Summit’s PD-1xVEGF combos with $2B investment
Sep 29, 2026 3:07am
Roche drops obesity antibody after flunked interim analysis
Sep 28, 2026 11:03am
Mirum posts ph. 3 hepatitis win for challenger to Gilead, Vir
Sep 28, 2026 9:36am
See more stories